Wenliang Tan

2PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 12, 2025
Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.

Hongkai Zhuang, Chenwei Tang, Wentao Wang

|Apr 18, 2025
GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma.

Yingzheng Tan, Lei Yang, Tao Xu

Pageof 1

Frequent Collaborators

1 joint publications

Hongkai Zhuang

1 joint publications

Chenwei Tang

1 joint publications

Wentao Wang

1 joint publications

Bo Chen